Skip to main content
Top
Published in: BMC Neurology 1/2011

Open Access 01-12-2011 | Research article

Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study

Authors: Giovanni Zuliani, Michela Perrone Donnorso, Cristina Bosi, Angelina Passaro, Edoardo Dalla Nora, Amedeo Zurlo, Francesco Bonetti, Alessia F Mozzi, Claudio Cortese

Published in: BMC Neurology | Issue 1/2011

Login to get access

Abstract

Background

In central nervous system cholesterol cannot be degraded but is secreted into circulation predominantly in the form of its polar metabolite 24(S)-hydroxycholesterol (24S-OH-Chol). Some studies suggested an association between 24S-OH-Chol metabolism and different neurological diseases including dementia. A possible decrease in 24S-OH-Chol plasma levels has been reported late onset Alzheimer's disease (LOAD) and vascular dementia (VD), but results of previous studies are partially contradictory.

Methods

By high-speed liquid chromatography/tandem mass spectrometry we evaluated the plasma levels of 24S-OH-Chol in a sample of 160 older individuals: 60 patients with LOAD, 35 patients with VD, 25 subjects affected by cognitive impairment no-dementia (CIND), and 40 (144 for genetics study) cognitively normal Controls. We also investigated the possible association between PPARgamma Pro12Ala polymorphism and dementia or 24S-OH-Chol levels.

Results

Compared with Controls, plasma 24S-OH-Chol levels were higher in LOAD and lower in VD; a slight not-significant increase in CIND was observed (ANOVA p: 0.001). A positive correlation between 24S-OH-Chol/TC ratio and plasma C reactive protein (CRP) levels was found in the whole sample, independent of possible confounders (multiple regression p: 0.04; r2: 0.10). This correlation was strong in LOAD (r: 0.39), still present in CIND (r: 0.20), but was absent in VD patients (r: 0.08). The PPARgamma Pro12Ala polymorphism was not associated with the diagnosis of LOAD, VD, or CIND; no correlation emerged between the Ala allele and 24S-OH-Chol plasma levels.

Conclusions

Our results suggest that plasma 24S-OH-Chol levels might be increased in the first stages of LOAD, and this phenomenon might be related with systemic inflammation. The finding of lower 24S-OH-Chol concentrations in VD might be related with a more advanced stage of VD compared with LOAD in our sample, and/or to different pathogenetic mechanisms and evolution of these two forms of dementia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafström M, Holmén K, Ericsson K, Bäckman L, Ahlbom A, Winblad B: Prevalence of Alzheimer disease and other dementias in an elderly urban population: relationship with age, sex and education. Neurology. 1991, 41: 1886-1892.CrossRefPubMed Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafström M, Holmén K, Ericsson K, Bäckman L, Ahlbom A, Winblad B: Prevalence of Alzheimer disease and other dementias in an elderly urban population: relationship with age, sex and education. Neurology. 1991, 41: 1886-1892.CrossRefPubMed
2.
go back to reference Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, Hofman A: Prevalence of Alzheimer disease and vascular dementia: association with education. The Rotterdam Study. British Medical Journal. 1995, 310: 970-973.CrossRefPubMedPubMedCentral Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, Hofman A: Prevalence of Alzheimer disease and vascular dementia: association with education. The Rotterdam Study. British Medical Journal. 1995, 310: 970-973.CrossRefPubMedPubMedCentral
3.
go back to reference Liu Y, Peterson DA, Schubert D: Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc Natl Acad Sci USA. 1998, 95: 13266-71. 10.1073/pnas.95.22.13266.CrossRefPubMedPubMedCentral Liu Y, Peterson DA, Schubert D: Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc Natl Acad Sci USA. 1998, 95: 13266-71. 10.1073/pnas.95.22.13266.CrossRefPubMedPubMedCentral
4.
go back to reference Björkhem I, Meaney S: Brain Cholesterol: Long secret life behind a barrier. Atheroscler Thromb Vasc Biol. 2004, 24: 806-815. 10.1161/01.ATV.0000120374.59826.1b.CrossRef Björkhem I, Meaney S: Brain Cholesterol: Long secret life behind a barrier. Atheroscler Thromb Vasc Biol. 2004, 24: 806-815. 10.1161/01.ATV.0000120374.59826.1b.CrossRef
5.
go back to reference Dietschy JM, Turley SD: Cholesterol metabolism in the brain. Curr Opin Lipidol. 2001, 12: 105-112. 10.1097/00041433-200104000-00003.CrossRefPubMed Dietschy JM, Turley SD: Cholesterol metabolism in the brain. Curr Opin Lipidol. 2001, 12: 105-112. 10.1097/00041433-200104000-00003.CrossRefPubMed
6.
go back to reference Brown MS, Goldstein JL: The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997, 89: 331-340. 10.1016/S0092-8674(00)80213-5.CrossRefPubMed Brown MS, Goldstein JL: The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997, 89: 331-340. 10.1016/S0092-8674(00)80213-5.CrossRefPubMed
7.
go back to reference Wolozin B, Brown J, Theisler C, Silberman S: The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease. CNS Drug Rev. 2004, 10: 127-146.CrossRefPubMed Wolozin B, Brown J, Theisler C, Silberman S: The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease. CNS Drug Rev. 2004, 10: 127-146.CrossRefPubMed
8.
go back to reference Leoni V, Caccia C: Oxysterols as biomarkers in neurodegenerative diseases. Chem Phys Lipids. 2011, 164 (6): 515-24. 10.1016/j.chemphyslip.2011.04.002. Epub 2011 Apr 16CrossRefPubMed Leoni V, Caccia C: Oxysterols as biomarkers in neurodegenerative diseases. Chem Phys Lipids. 2011, 164 (6): 515-24. 10.1016/j.chemphyslip.2011.04.002. Epub 2011 Apr 16CrossRefPubMed
9.
go back to reference Papassotiropoulos A, Lutjohann D, Bagli M, Locatelli S, Jessen F, Buschfort R, Ptok U, Bjorkhem I, von Bergmann K, Heun R: 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J Psychiatr Res. 2002, 36: 27-32. 10.1016/S0022-3956(01)00050-4.CrossRefPubMed Papassotiropoulos A, Lutjohann D, Bagli M, Locatelli S, Jessen F, Buschfort R, Ptok U, Bjorkhem I, von Bergmann K, Heun R: 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J Psychiatr Res. 2002, 36: 27-32. 10.1016/S0022-3956(01)00050-4.CrossRefPubMed
10.
go back to reference Schonknecht P, Lutjohann D, Pantel J, Bardenheuer H, Hartmann T, von Bergmann K, Beyreuther K, Schroeder J: Cerebrospinal fluid 24-S-hydroxicholesterol is increased in patients with Alzheimer's disease compared to healthy controls. Neurosci Lett. 2002, 10: 83-85.CrossRef Schonknecht P, Lutjohann D, Pantel J, Bardenheuer H, Hartmann T, von Bergmann K, Beyreuther K, Schroeder J: Cerebrospinal fluid 24-S-hydroxicholesterol is increased in patients with Alzheimer's disease compared to healthy controls. Neurosci Lett. 2002, 10: 83-85.CrossRef
11.
go back to reference Heverin M, Bogdanovic N: Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J Lipid Res. 2004, 45: 186-93.CrossRefPubMed Heverin M, Bogdanovic N: Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J Lipid Res. 2004, 45: 186-93.CrossRefPubMed
12.
go back to reference Lütjohann D, Papassotiropoulos A, Björkhem I, Locatelli S, Bagli M, Randi DO, Schlegel U, Jessen F, Rao ML, von Bergmann K, Heun R: Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res. 2000, 451: 195-98. Lütjohann D, Papassotiropoulos A, Björkhem I, Locatelli S, Bagli M, Randi DO, Schlegel U, Jessen F, Rao ML, von Bergmann K, Heun R: Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res. 2000, 451: 195-98.
13.
go back to reference Bretillon L, Siden A, Wahlung LO, Lütjohann D, Minthon L, Crisby M, Hillert J, Groth CG, Diczfalusy U, Björkhem I: Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci Lett. 2000, 293: 87-90. 10.1016/S0304-3940(00)01466-X.CrossRefPubMed Bretillon L, Siden A, Wahlung LO, Lütjohann D, Minthon L, Crisby M, Hillert J, Groth CG, Diczfalusy U, Björkhem I: Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci Lett. 2000, 293: 87-90. 10.1016/S0304-3940(00)01466-X.CrossRefPubMed
14.
go back to reference Kolsch H, Heun R, Kerksiek A, Bergmann KV, Maier W, Lütjohann D: Altered levels of plasma 24S-hydroxycholesterol in demented patients. Neurosci Lett. 2004, 368: 303-8. 10.1016/j.neulet.2004.07.031.CrossRefPubMed Kolsch H, Heun R, Kerksiek A, Bergmann KV, Maier W, Lütjohann D: Altered levels of plasma 24S-hydroxycholesterol in demented patients. Neurosci Lett. 2004, 368: 303-8. 10.1016/j.neulet.2004.07.031.CrossRefPubMed
15.
go back to reference Solomon A, Leoni V, Kivipelto M, Besga A, Oksengard AR, Julin P, Svenson L, Wahlund LO, Andreasen N, Winblad B, Soininen H, Björkhem I: Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. Neurosci Lett. 2009, 462: 89-93. 10.1016/j.neulet.2009.06.073.CrossRefPubMed Solomon A, Leoni V, Kivipelto M, Besga A, Oksengard AR, Julin P, Svenson L, Wahlund LO, Andreasen N, Winblad B, Soininen H, Björkhem I: Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. Neurosci Lett. 2009, 462: 89-93. 10.1016/j.neulet.2009.06.073.CrossRefPubMed
16.
go back to reference Kolsch H, Lutjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, Heun R: Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Molecular Psychiatry. 2002, 7: 899-902. 10.1038/sj.mp.4001109.CrossRefPubMed Kolsch H, Lutjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, Heun R: Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Molecular Psychiatry. 2002, 7: 899-902. 10.1038/sj.mp.4001109.CrossRefPubMed
17.
go back to reference Sauder S, Kölsch H, Lütjohann D, Schulz A, von Bergmann K, Maier W, Heun R: Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients. J Neural Transm. 2005, 112: 1381-9. 10.1007/s00702-004-0267-z.CrossRefPubMed Sauder S, Kölsch H, Lütjohann D, Schulz A, von Bergmann K, Maier W, Heun R: Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients. J Neural Transm. 2005, 112: 1381-9. 10.1007/s00702-004-0267-z.CrossRefPubMed
18.
go back to reference McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical Diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984, 34: 939-944.CrossRefPubMed McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical Diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984, 34: 939-944.CrossRefPubMed
19.
go back to reference Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Ofman A, Moody MD, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata Y, Kokmen E, Bermejo F, Wolf PA, Gorelich PB, Bich KL, Pajeau AK, Bell MA, De Carli C, Culebras A, Korczyn AD, Bogouslavsky J, Hartmann A, Scheinberg P: Vascular dementia: diagnostic criteria for research study. Neurology. 1993, 43: 250-260.CrossRefPubMed Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Ofman A, Moody MD, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata Y, Kokmen E, Bermejo F, Wolf PA, Gorelich PB, Bich KL, Pajeau AK, Bell MA, De Carli C, Culebras A, Korczyn AD, Bogouslavsky J, Hartmann A, Scheinberg P: Vascular dementia: diagnostic criteria for research study. Neurology. 1993, 43: 250-260.CrossRefPubMed
20.
go back to reference Zuliani G, Ranzini M, Guerra G, Rossi L, Munari MR, Zurlo A, Volpato S, Atti AR, Blè A, Fellin R: Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia. J Psychiatr Res. 2007, 41: 686-693. 10.1016/j.jpsychires.2006.02.008.CrossRefPubMed Zuliani G, Ranzini M, Guerra G, Rossi L, Munari MR, Zurlo A, Volpato S, Atti AR, Blè A, Fellin R: Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia. J Psychiatr Res. 2007, 41: 686-693. 10.1016/j.jpsychires.2006.02.008.CrossRefPubMed
21.
go back to reference DeBarber AE, Lutjohann D, Merkens L, Steiner RD: Liquid chromatography tandem mass spectrometry determination of plasma 24S-hydroxycholesterol with chromatographic separation of 25-hydroxycholesterol. Anal Biochem. 2008, 381: 151-3. 10.1016/j.ab.2008.05.037.CrossRefPubMedPubMedCentral DeBarber AE, Lutjohann D, Merkens L, Steiner RD: Liquid chromatography tandem mass spectrometry determination of plasma 24S-hydroxycholesterol with chromatographic separation of 25-hydroxycholesterol. Anal Biochem. 2008, 381: 151-3. 10.1016/j.ab.2008.05.037.CrossRefPubMedPubMedCentral
22.
go back to reference Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J, Shuldiner AR: Molecular scanning of the human peroxisome proliferator activated receptor gamma (PPARgamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun. 1997, 18: 270-4.CrossRef Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J, Shuldiner AR: Molecular scanning of the human peroxisome proliferator activated receptor gamma (PPARgamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun. 1997, 18: 270-4.CrossRef
23.
go back to reference Brown J, Theisler C, Silberman S, Magnuson D, Gottardi-Littell N, Lee JM, Yager D, Crowley J, Sambamurti K, Rahman MM, Reiss AB, Eckman CB, Wolozin B: Differential expression of cholesterol hydroxylases in Alzheimer's disease. J Biol Chem. 2004, 279: 34674-81. 10.1074/jbc.M402324200.CrossRefPubMed Brown J, Theisler C, Silberman S, Magnuson D, Gottardi-Littell N, Lee JM, Yager D, Crowley J, Sambamurti K, Rahman MM, Reiss AB, Eckman CB, Wolozin B: Differential expression of cholesterol hydroxylases in Alzheimer's disease. J Biol Chem. 2004, 279: 34674-81. 10.1074/jbc.M402324200.CrossRefPubMed
24.
go back to reference Elovaara I, Palo J, Erkinjuntti T, Sulkava R: Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimer's disease and multi-infarct dementia. Eur Neurol. 1987, 26: 229-234. 10.1159/000116341.CrossRefPubMed Elovaara I, Palo J, Erkinjuntti T, Sulkava R: Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimer's disease and multi-infarct dementia. Eur Neurol. 1987, 26: 229-234. 10.1159/000116341.CrossRefPubMed
25.
go back to reference Bjorkhem J: Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med. 2006, 260: 493-508. 10.1111/j.1365-2796.2006.01725.x.CrossRefPubMed Bjorkhem J: Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med. 2006, 260: 493-508. 10.1111/j.1365-2796.2006.01725.x.CrossRefPubMed
26.
go back to reference Alexandrov P: 24S-hydroxycholesterol induces inflammatory gene expression in primary human neural cells. Molecular Neuroscience. 2005, 9: 909-913. Alexandrov P: 24S-hydroxycholesterol induces inflammatory gene expression in primary human neural cells. Molecular Neuroscience. 2005, 9: 909-913.
27.
go back to reference Ferrè P: The biology of peroxisome proliferator-activated receptors. relationship with lipid metabolism and insulin sensitivity. Diabetes. 2004, 53: S43-50. 10.2337/diabetes.53.2007.S43.CrossRefPubMed Ferrè P: The biology of peroxisome proliferator-activated receptors. relationship with lipid metabolism and insulin sensitivity. Diabetes. 2004, 53: S43-50. 10.2337/diabetes.53.2007.S43.CrossRefPubMed
28.
go back to reference Carantoni M, Zuliani G, Munari MR, D'Elia K, Palmieri E, Fellin R: Alzheimer and vascular dementia: relationships with fasting glucose and insulin levels. Dem Geriatric Cogn Dis. 2000, 11: 176-180. 10.1159/000017232.CrossRef Carantoni M, Zuliani G, Munari MR, D'Elia K, Palmieri E, Fellin R: Alzheimer and vascular dementia: relationships with fasting glucose and insulin levels. Dem Geriatric Cogn Dis. 2000, 11: 176-180. 10.1159/000017232.CrossRef
29.
go back to reference Stewart R, White LR, Xue QL, Launer LJ: Twenty-six-year change in total cholesterol levels and incident dementia. Arch Neurol. 2007, 64: 103-107. 10.1001/archneur.64.1.103.CrossRefPubMed Stewart R, White LR, Xue QL, Launer LJ: Twenty-six-year change in total cholesterol levels and incident dementia. Arch Neurol. 2007, 64: 103-107. 10.1001/archneur.64.1.103.CrossRefPubMed
Metadata
Title
Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study
Authors
Giovanni Zuliani
Michela Perrone Donnorso
Cristina Bosi
Angelina Passaro
Edoardo Dalla Nora
Amedeo Zurlo
Francesco Bonetti
Alessia F Mozzi
Claudio Cortese
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2011
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-11-121

Other articles of this Issue 1/2011

BMC Neurology 1/2011 Go to the issue